ITMCTR2200006829招募中1 期
Efficacy and safety evaluation of modified Yin Qiao San in the treatment of COVID-19 --A randomized, double-blind, placebo-controlled clinical trial
The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Traditional Chinese Medicine)0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 性别
- All
入选标准
- •1. Meet the diagnostic criteria of the Diagnosis and Treatment Program for Novel Coronavirus Pneumonia (Trial Ninth Edition);
- •2. Age 18-60 (including boundary value);
- •3. The subjects or their legal representatives signed the informed consent.
排除标准
- •1. The subject has received antiviral treatment before entering the study, such as Paxlovid, ritonavir tablets, and SARS-CoV-2 monoclonal antibody treatment (except for the treatment of previous new crown infection);
- •2. Subjects have received convalescent plasma from convalescents and other clinical trial drugs with indications for new coronary pneumonia before entering the study (except for the treatment of previous new coronary infection);
- •3. Bacteria, fungi, viruses or other infections other than the new coronavirus are suspected during the screening period;
- •4. Need mechanical ventilation or expect to urgently need mechanical ventilation;
- •5. According to the investigator's judgment, the subject has a death crisis or death is inevitable in the next 24 hours, no matter what treatment is given;
- •6. Have used other experimental drugs 30 days before the baseline visit or within the five half-lives of the drug (the longer time is selected between the two) or during the planned study period;
- •7. Subjects participated in other clinical research within 30 days before the screening period;
- •8. Pregnant, lactating or lactating female subjects;
- •9. Allergic constitution or allergy to known research drugs;
研究者
相似试验
已完成
不适用
Efficacy and safety of Yijin-tang on polycystic ovarian syndrome: A single-arm pilot studyEndocrine, nutritional and metabolic diseaseKCT0002749Kyung Hee University Oriental Medicine Hospital at Gangdong15
尚未招募
1 期
Study for the Effectiveness and Safety of Yi-Qi Hua-shi Jie-Du-Fang in the Treatment of the Novel Coronavirus Pneumonia (COVID-19)ovel Coronavirus Pneumonia (COVID-19)ITMCTR2000003080Affiliated Hospital of traditional Chinese and Western Medicine Nanjing University of Chinese Medicine
招募中
不适用
The curative effect evaluation for Yi-Qi Yang-Yin Huo-Xue prescription in treatment of the high risk population of hepatitis B cirrhosis with chronic kidney injurychronic kidney diseaseITMCTR1900002717Beijing Ditan Hospital Affiliated to Capital Medical University
尚未招募
1 期
Evaluation of efficacy and safety of Qiangzhu-qinggan formula as an adjunctive therapy in adult patients with severe influenzainfluenzaITMCTR2000002885onghua Hospital Shanghai University of Traditional Chinese Medicine
尚未招募
1 期
Efficacy, Safety and Mechanism of Modified Xianyaoyin in Patients with Mild to Moderate Hypertriglyceridemia: A Study Protocol for a Multicenter and Randomized Controlled TrialHypertriglyceridemiaITMCTR2200006417Xiyuan Hospital, China Academy of Chinese Medical Sciences